Recent Advances in Point-of-Care Diagnostics for Cardiac Markers

about

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers

Item

http://www.wikidata.org/entity/Q37155277

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 04 September 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers

@en

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers.

@nl

type

Item

label

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers

@en

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers.

@nl

prefLabel

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers

@en

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers.

@nl

P1476

Recent Advances in Point-of-Care Diagnostics for Cardiac Markers

@en

P2093

H B Wu Alan

http://www.w3.org/2001/XMLSchema#string

P2860

Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction).

Human/mouse chimeric antibodies show low reactivity with human anti-murine antibodies (HAMA).

Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

Novel biomarkers in cardiovascular disease: update 2010.

Analytical and assay issues for use of cardiac troponin testing for risk stratification in primary care.

Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department.

Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I.

Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay.

P304

170-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27683464

http://www.w3.org/2001/XMLSchema#string

P932

4975292

http://www.w3.org/2001/XMLSchema#string